Search results
Pfizer sued by Kansas for allegedly hiding COVID vaccine risks, making false claims
NY Post via Yahoo News· 6 days agoThe lawsuit claims that, beginning shortly after the vaccine's rollout in early 2021, Pfizer...
Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks
Motley Fool via Yahoo Finance· 7 hours agoInvestors who are attracted to truly passive income generation may want to consider AT&T (NYSE: T),...
Pfizer CEO’s COVID-19 ‘rehearsal’ comment out of context
Politifact· 14 hours agoA Threads post took a year-old statement by Pfizer CEO Albert Bourla out of context to say the...
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 6 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 6 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19...
Apella Capital LLC Trims Stock Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoApella Capital LLC decreased its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 3.0% during the 1st quarter, according to its most recent 13F filing with the ...
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold | The Motley Fool
The Motley Fool· 1 day agoInvestors looking for high-yield dividend stocks to buy now should turn their attention toward the...
Kansas sues Pfizer over ‘misleading statements’ about COVID vaccine
The Hill via AOL· 6 days agoThe state of Kansas filed a lawsuit Monday against pharmaceutical company Pfizer, alleging the...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 1 day agoHere's why they picked AstraZeneca (NASDAQ: AZN), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). AstraZeneca is a growth beast with loads of...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remained trapped below a...